Trial reportApplied psychophysiology and biofeedback2025
The Effect of Electroencephalographic Biofeedback Therapy on Anxiety and Overall Well-being in Patients with Rectal Cancer.
Trial report in Applied psychophysiology and biofeedback, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Beyond survival: psychoneuroimmunology-driven cancer psychological rehabilitation-a paradigm shift from symptom management to biobehavioral remodeling.Frontiers in oncology · 2026Review
- Biofeedback in Pediatric, Adolescent, and Young Adult Cancer Care: A Systematic Review.Children (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the effectiveness of electroencephalographic (EEG) biofeedback therapy in reducing anxiety levels and improving overall well-being among patients diagnosed with rectal cancer. A randomised controlled trial was conducted with 150 patients with rectal cancer who were randomly assigned to either the intervention group (n = 75) or the control group (n = 75). The intervention group received 16 sessions of EEG biofeedback therapy over 8 weeks, whereas the control group received standard care. Anxiety levels were assessed using the State-Trait Anxiety Inventory at baseline, post-intervention, 3-month follow-up, 6-month follow-up and 12-month follow-up. Secondary outcomes, including quality of life, sleep quality, treatment adherence, cortisol levels and heart rate variability (HRV), were also evaluated. The intervention group showed significant reductions in state anxiety (p < 0.001) and trait anxiety (p < 0.001) compared with the control group at all post-intervention time points. Significant improvements were also observed in the intervention group for quality of life (p < 0.001), sleep quality (p < 0.001), treatment adherence (p < 0.001), cortisol levels (p < 0.01) and HRV (p < 0.01). The effects were maintained at the 12-month follow-up. Electroencephalographic biofeedback therapy is an effective non-pharmacological intervention for reducing anxiety levels and improving overall well-being in patients with rectal cancer. The findings suggest that incorporating EEG biofeedback therapy into the standard care of patients with rectal cancer may enhance their psychological well-being, quality of life, sleep quality, treatment adherence, physiological stress responses and autonomic function. Long-term benefits were observed, indicating the sustainability of the intervention's effects. Further research is warranted to investigate the underlying mechanisms and potential applications of EEG biofeedback therapy in other cancer populations.
Indexed as
Identifiers
40072794What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.